Raxone, comprimé pelliculé

7680680630013 CH-68063 Tabletten
Raxone, comprimé pelliculé
Raxone, comprimé pelliculé
Raxone, comprimé pelliculé
1 / 3
google

Article details

Package size
180
Selling units
180
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/06/2024
Patient information leaflet
Français
28/06/2024
Patient information leaflet
Italien
28/06/2024
Summary of Product Characteristics
Allemand
28/06/2024
Summary of Product Characteristics
Français
28/06/2024
Summary of Product Characteristics
Italien
28/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
48.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.49 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
1.275 MG Substance HBESI

Authorization holder

Chiesi SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
68063
Drug name
Raxone, comprimé pelliculé
Galenic form
FILM
ATC Code
N06BX13
Authorization status
Z
Dispensing category
B
First authorization
01/03/2024
Authorization expiration date
28/02/2029
IT Number
01.99.0.
Domain
Human medicine

Package details

Description (FR)
RAXONE cpr pell 150 mg bte 180 pce
Description (DE)
RAXONE Filmtabl 150 mg Ds 180 Stk
Market launch
01/03/2024
Narcotic (BTM)
No